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Tumor necrosis factor-α (TNF-α) regulates a
variety of biologic functions, including organ
development, immune homeostasis, and
malignance. The body subtly regulates the
expression kinetics and dose of TNF-α to
ensure its proper effect because TNF-α has
opposite biologic effects in different circum-
stances (Aggarwal 2003; Pfeffer 2003). On the
one hand, TNF-α is essential for the host in
tissue repair and in protective immune
responses against infection. On the other
hand, inadequate TNF-α may have detrimen-
tal consequences in sepsis, tumor formation,
and autoimmune diseases. Regulating the
expression of TNF-α has been an important
subject in managing acute inﬂammatory dis-
eases that include bacterial sepsis (Spooner
et al. 1992). Recent studies on chronic neu-
ronal disease revealed a new feature of inﬂam-
mation: a transient spike of TNF-α expression
(i.e., a large amount that peaks after 1.5 hr
and disappears after 3 hr) may induce neu-
ronal degeneration resembling the delayed and
progressive nature of the symptoms in patients
with Parkinson’s disease (Gao et al. 2002).
These findings indicate that the extent of
TNF-α expression during a disease deter-
mines not only severity and survival rate but
also delayed disease sequelae.
The in vivo lipopolysaccharide (LPS)-
induced model of liver damage of mice, used to
determine TNF-α–mediated organ failure, is
both sensitive and convenient. LPS, a compo-
nent of the outer membrane of gram-negative
bacteria, plays a major role in inducing septic
shock and is a potent inducer of TNF-α
in vivo and in vitro (Goldfeld et al. 1990;
Ulich et al. 1991). The binding of LPS to
CD14/LPS-binding protein and Toll-like
receptor-4 triggers multiple signal cascades
that activate nuclear factor-κB and p42/44
mitogen-activated protein kinase (MAPK)
and lead to the expression of proinﬂammatory
cytokines, including TNF-α (Triantaﬁlou and
Triantaﬁlou 2002). LPS causes liver injury at
high doses (Kosai et al. 1999) but a modest,
noninjurious inflammation at low doses
(Ganey and Roth 2001) in several animal
models. High-dose LPS-induced liver injury is
partly attributed to excess TNF-α production
(Hewett et al. 1993). TNF-α–associated signal
transduction has been well characterized.
TNF-α might trigger apoptosis in hepatocytes
by signaling through the Fas-associated death-
domain protein of the TNF receptor that acti-
vates caspases (Leist et al. 1996; Schuchmann
et al. 2003). Blocking TNF production or
trimming the signaling pathway using caspase-
inhibitors reduces TNF-α–mediated liver
injury (Kunstle et al. 1997). In addition, LPS
induces apoptosis in macrophages through
TNF-α (Comalada et al. 2003). Convincing
evidence shows that metal pollutants in the liv-
ing environment may modulate the effects of
LPS. Among them, lead, an important indus-
trial pollutant, not only altered the immune
response (Luster et al. 1978) but also increased
the mortality of an LPS challenge or bacterial
infections in several animal studies (Dentener
et al. 1989; Selye et al. 1966). Thus, the inﬂu-
ence of environmental factors on TNF-α
production is a signiﬁcant issue.
Several pieces of evidence (Liu et al. 2001)
suggest that Pb might act on calcium channels
to alter intracellular calcium homeostasis in
bone cells (Pounds 1984; Rosen and Pounds
1989; Schanne et al. 1989) and neuronal cells
(Goldstein 1993; Pounds 1984; Rosen and
Pounds 1989; Schanne et al. 1989). Although
the cellular target of Pb is still elusive, expo-
sure to Pb activates protein kinase C (PKC) in
several types of cells, such as astrocytes and
neuronal cells in the brain (Costa 1998;
Markovac and Goldstein 1988). We previ-
ously (Cheng et al. 2004) demonstrated that
Pb stimulates PKC to activate p42/44 MAPK,
which results in the expression of TNF-α in
glial cells. Although LPS and Pb trigger intra-
cellular signals by different routes, Pb
increases LPS-induced TNF-α production
(Liu et al. 2005). Coexposure to Pb plus LPS
also induces TNF-α expression through PKC
and p42/44 MAPK, causing liver injury in
rats (Cheng and Liu 2005). In this study, we
measured the liver injury in mice as the bio-
logic end point for exploring the mechanism
of Pb-increased/LPS-induced TNF-α expres-
sion. Thus, the aims of this study were to
identify the cells in the blood responsible for
TNF-α release and to reveal the role of PKC
and p42/44 MAPK in the induction of
TNF-α during coexposure to Pb plus LPS.
Materials and Methods
Chemicals. We obtained LPS (derived from
Escherichia coli, serotype 055:B5), TNF-α
inhibitor pentoxifylline (PTX), and macro-
phage cytotoxic agent GdCl3–6H2O (gadolin-
ium chloride hexahydrate) from Sigma
Chemical (St. Louis, MO, USA). Lead acetate
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Although lead and lipopolysaccharide (LPS), both important environmental pollutants, activate cells
through different receptors and participate in distinct upstream signaling pathways, Pb increases the
amount of LPS-induced tumor necrosis factor-α (TNF-α). We examined the cells responsible for the
excess production of Pb-increased LPS-induced TNF-α and liver injury, and the roles of protein
kinase C (PKC) and p42/44 mitogen-activated protein kinase (MAPK) in the induction of TNF-α.
Peritoneal injection of Pb alone (100 µmol/kg) or a low dose of LPS (5 mg/kg) did not affect serum
TNF-α or liver functions in A/J mice. In contrast, coexposure to these noneffective doses of Pb plus
LPS (Pb+LPS) strongly induced TNF-α expression and resulted in profound liver injury. Direct
inhibition of TNF-α or functional inactivation of monocytes/macrophages signiﬁcantly decreased
the level of Pb+LPS-induced serum TNF-α and concurrently ameliorated liver injury. Pb+LPS coex-
posure stimulated the phosphorylation of p42/44 MAPK and the expression of TNF-α in CD14+
cells of cultured mouse whole blood, peritoneal macrophages, and RAW264.7 cells. Moreover,
blocking PKC or MAPK effectively reduced Pb+LPS-induced TNF-α expression and liver injury. In
summary, monocytes/macrophages were the cells primarily responsible for producing, through the
PKC/MAPK pathway, the excess Pb-increased/LPS-induced TNF-α that caused liver injury.
Key words: lead, lipopolysaccharide, liver injury, monocytes/macrophage, p42/44 mitogen-activated
protein kinase, protein kinase C, tumor necrosis factor-α. Environ Health Perspect 114:507–513
(2006). doi:10.1289/ehp.8550 available via http://dx.doi.org/ [Online 10 November 2005]was purchased from Merck (Darmstadt,
Germany). PKC inhibitor chelerythrine chlo-
ride (C21H18NO4Cl) was obtained from
Calbiochem (Bad Soden, Germany), and
p42/44 MAPK inhibitor U0126 was pur-
chased from Promega (Madison, WI, USA).
Cells and animals. Peritoneal macrophages
were isolated by ﬂushing the peritoneal cavity
of A/J mice with 10 mL of sterile ice-cold
phosphate buffer. Peritoneal lavage ﬂuid was
centrifuged at 200g, and pelleted cells were
resuspended in Dulbecco’s modified Eagle
medium (DMEM) supplemented with 10%
fetal bovine serum (FBS), penicillin, and
streptomycin (100 U/mL). Cells were then
seeded at 2 × 105/well in a 96-well plate, incu-
bated at 37°C for 4 hr, and washed with phos-
phate-buffered saline (PBS) to remove
unattached cells. Attached cells, taken as
macrophages and conﬁrmed with F4/80 stain,
were used for sequential experiments.
RAW264.7 cells, a mouse macrophage cell line
(American Type Culture Collection, Rockville,
MD, USA), were cultured in DMEM supple-
mented with 10% FBS. A/J mice weighing
20–25 g were obtained from and housed in the
laboratory animal center of our institution.
Animals were housed individually in a room
with a 12/12-hr light/dark cycle and central
air-conditioning (25°C, 70% humidity), and
were fed with standard food ad libitum. The
animal experiment procedures were reviewed
and implemented through the Institutional
Animal Care and Use Committee process of
National Cheng Kung University.
Blood collection and biochemistry study.
The blood of mice was collected from the
inferior vena cava under ethyl ether anesthesia,
drawn using venipuncture into serum separa-
tion tubes, allowed to clot for 10 min at room
temperature, and then centrifuged (1,000g, 10
min, 4°C). Serum samples were stored at
70°C. To determine the serum concentrations
of aspartate aminotransferase (AST) and
alanine aminotransferase (ALT), serum was
spotted to slides (Fuji Dri-Chem; Fujifilm,
Kanagawa, Japan) and evaluated using a slide
analyzer (Fuji Dri-Chem 3500S; Fujiﬁlm).
Preparation of mouse whole-blood and
cytokine assays. Induction of TNF-α in mouse
whole blood was performed as described pre-
viously (Mullarkey et al. 2003). Briefly, Pb
and LPS were added to heparinized whole
blood obtained from A/J mice (100 µL/well).
After 2 hr incubation at 37°C in a 5% CO2
atmosphere, the blood was centrifuged at
1,000g for 10 min at 4°C. TNF-α in condi-
tioned medium was determined using
enzyme-linked immunosorbent assay (ELISA)
(R&D Systems, Minneapolis, MN, USA),
measuring absorbance at 450 nm and extrapo-
lating from a standard curve with a sensitivity
limit of 32.5 pg/mL.
Flow cytometric analysis. To identify the
TNF-α–secreting cells, Pb or LPS was added
to whole blood with monensin (eBioscience,
San Diego, CA, USA). Red blood cells were
lysed using hypotonic shock, and leukocytes
were subjected to surface CD14 labeling
using phycoerythrin-conjugated CD14 anti-
body (eBioscience). Cells were ﬁxed and per-
meabilized using a commercial kit (Cytofix/
Cytoperm; PharMingen, San Diego, CA, USA)
and stained for intracellular TNF-α using ﬂuo-
rescein isothiocyanate (FITC)-conjugated rat
anti-mouse TNF-α Ab (PharMingen). To ana-
lyze the phosphorylation status of p42/44
MAPK in peritoneal macrophages, exudate
cells were ﬁxed using 2% formaldehyde; they
were then resuspended in methanol at a con-
centration of 90%. Cells were incubated with
the primary phospho-p42/44 MAPK anti-
body (New England Biolabs, Beverly, MA,
USA) for 30 min at room temperature. After
being washed in PBS containing 0.5% FBS,
secondary antibody hybridization was carried
out using goat anti-rabbit IgG (Alexa Fluor
488; Molecular Probes, Eugene, OR, USA).
Macrophage-specific marker F4/80 was first
stained with biotin-conjugated anti-F4/80
antibody and then with phycoerythrin-
conjugated streptavidin secondary antibody
(eBioscience). Flow cytometric analysis was
then performed (FACSCalibur; Becton
Dickinson, San Jose, CA, USA). Data were
analyzed using the CellQuest (BD Biosciences,
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Figure 1. Expression of TNF-α (A), AST (B), and ALT (C) in A/J mice exposed to Pb, LPS, Pb+LPS, or saline (control). ND, not detectable. Blood was collected 1.5 hr
after treatment to determine serum TNF-α (A). Serum AST (B) and ALT (C) were evaluated 24 hr posttreatment. n = 3 per treatment.
*p < 0.05 compared with LPS.
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Figure 2. Histologic examination of liver damage in A/J mice challenged with Pb (B, F, J, N, R), LPS (C, G, K,
O, S), Pb+LPS (D, H, L, P, T), or saline (control) (A, E, I, M, Q). To evaluate the effects of corresponding
inhibitors, mice were pretreated with PTX (100 mg/kg) for 60 min (E, F, G, H), GdCl3 (40 mg/kg) for 24 hr (I, J,
K, L), or C21H18NO4Cl (5 mg/kg) for 30 min (M, N, O, P), or U0126 (25 µmol/kg) for 10 min (Q, R, S, T). Mice
were sacriﬁced after 24 hr. Arrows in (D) indicate the necrosis area. Tissue was stained with hematoxylin
and eosin. Bars = 0.04 mm.San Jose, CA, USA) and WinMDI 2.8 soft-
ware packages (University of Massachusetts,
Amherst, MA, USA).
Western blot analysis. RAW264.7 cells
were cultured in 0.01% FBS/DMEM for
30 min and sequentially stimulated with Pb
(10 µM), LPS (1 ng/mL), Pb (10 µM) plus
LPS (Pb+LPS) (1 ng/mL), or saline (control).
After stimulation, cells were washed with cold
PBS and then solubilized with ice-cold buffer
containing 25 mM HEPES (pH 7.5),
300 mM NaCl, 1.5 mM MgCl2, 0.2 mM
EDTA, 0.1% Triton X-100, 20 mM β-glyc-
erophosphate, 0.1 mM sodium orthovana-
date, 0.5 mM dithiothreitol, 100 µg/mL
phenylmethylsulfonyl ﬂuoride, and 2 µg/mL
leupeptin. Approximately 10–30 µg of protein
was separated using electrophoresis in a 10%
sodium dodecyl sulfate–polyacrylamide gel.
After electrophoresis, the protein was electro-
transferred onto polyvinylidene ﬂuoride mem-
branes (NEN Life Science Products, Inc.,
Boston, MA, USA). Membranes were probed
with antibodies specific for phospho-p42/44
MAPK or p42/44 MAPK (New England
Biolabs). After being probed with a horseradish
peroxidase–conjugated secondary antibody,
protein signals were visualized using enhanced
chemiluminescence reagents (Amersham,
Arlington Heights, IL, USA) combined with
Kodak X-ML ﬁlm exposure (Eastman-Kodak,
Rochester, NY, USA).
Histology. Liver tissue obtained from mice
was fixed in 3.7% buffered formalin and
embedded in paraffin. Sections (5 µm) were
routinely stained with hematoxylin and eosin
Y stain.
Statistical analysis. Data are expressed as
mean ± SE. We used one-way or two-way
analysis of variance and Student’s t-test.
Statistical signiﬁcance was set at p < 0.05.
Results
Expression of TNF-α and liver injury in
mice after coexposure to Pb plus LPS. We
evaluated the role of TNF-α in Pb-increased
LPS-induced liver injury. A/J mice were
intraperitoneally given Pb (100 µmol/kg)
(Shinozuka et al. 1996), LPS (5 mg/kg)
(Ohta and Sitkovsky 2001), Pb+LPS (Pb,
100 µmol/kg; LPS, 5 mg/kg), or saline (con-
trol). Blood was collected 1.5 hr later to
determine serum TNF-α (Figure 1A) and
24 hr later to measure the levels of AST
(Figure 1B) and ALT (Figure 1C) that indi-
cate liver injury. Histologic examination of
the liver was performed 24 hr posttreatment
(Figure 2). Serum TNF-α was not detected in
mice that received saline or Pb alone. Mice
challenged with LPS alone showed a small
amount of serum TNF-α (< 250 pg/mL) and a
slight increase in AST (300 U/L) and ALT
(30 U/L). However, we observed few histologic
changes indicating hepatocellular damage in
mice that received saline (Figure 2A), Pb alone
(Figure 2B), or LPS alone (Figure 2C). Pb sig-
niﬁcantly increased LPS-induced TNF-α pro-
duction in mice treated with Pb+LPS. The
induction of serum TNF-α by LPS was drasti-
cally increased by Pb that reached around
2,000 pg/mL in 1.5 hr. Concurrently, the
mean levels of AST and ALT were signiﬁcantly
elevated in the Pb+LPS group to 720 U/L and
600 U/L, respectively. In addition, Pb+LPS-
treated mice showed multiple profoundly
necrotic areas in the liver (Figure 2D).
To establish a causal relationship between
TNF-α and liver injury, we used PTX, a
potent inhibitor of TNF transcription in vivo
(Lechner et al. 1993), to suppress the produc-
tion of TNF-α. Mice that had been given
PTX (100 mg/kg) 1 hr before Pb+LPS treat-
ment had lower serum TNF-α than did those
that had not been given PTX (Figure 3A).
Along with a decrease in TNF-α induction,
the Pb+LPS-stimulated AST (Figure 3B) and
ALT levels (Figure 3C) were also markedly
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Figure 3. Effects of TNF-α inhibitor on liver damage in A/J mice intraperitoneally injected with PTX (100 mg/kg) or H2O as vehicle (control). One hour later, mice were
stimulated with Pb, LPS, Pb+LPS, or saline only (control). ND, not detectable. Blood was collected either 1.5 hr after Pb, LPS, or Pb+LPS treatment to determine serum
TNF-α (A), or 24 hr posttreatment to determine serum AST (B) and ALT (C). n = 3 per treatment.
*p < 0.05 compared with Pb+LPS.
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Figure 4. TNF-α expression in cultured whole blood of mice. Whole blood was stimulated in vitro with LPS (5 µg/mL) with or without Pb acetate (1 µM) for 1.5 hr.
ND, not detectable. (A) TNF-α in serum measured by ELISA. (B) Density plot for blood cells from the Pb+LPS-treated group doubly stained for surface CD14 and
intracellular TNF-α (x-axis, TNF-α; y-axis, CD14) and analyzed using ﬂow cytometric analysis; the percentage shown is the ratio of TNF-α+ to CD14+ cells. (C)
Mean percentage of TNF-α+ cells in CD14+ population (mean ± SE) of groups treated with Pb, LPS, or Pb + LPS (n = 3–5 per treatment).
*p < 0.05 compared with LPS.attenuated by PTX. Moreover, PTX signifi-
cantly decreased the number of necrotic
hepatocellular lesions in Pb+LPS-treated mice
(Figure 2H).
TNF-α producing cells. We detected rare
TNF-α+ cells in the liver using immunohisto-
chemical staining (data not shown). We then
checked blood cells using an in vitro whole-
blood culture model. LPS (5 µg/mL) increased
the expression of mean TNF-α in whole-blood
culture to 75 pg/mL (mean value) in 1.5 hr.
Although Pb (1 µM) itself did not induce
detectable TNF-α, it signiﬁcantly increased the
TNF-α–inducing effect of LPS, which then
reached approximately 125 pg/mL (Figure 4A).
Because CD14+ macrophages/monocytes have
been documented as a major source of TNF-α
(Haziot et al. 1996), we analyzed the CD14+
cells in the whole-blood culture after Pb+LPS
coexposure. Using ﬂow cytometric analysis, we
determined whether CD14+ cells were the pri-
mary TNF-α–secreting cells in blood. The cells
were stained with phycoerythrin–anti-CD14
and FITC-anti-TNF-α after stimulation.
TNF-α+/CD14+ cells (5.9%) were separated
from single negative cells (Figure 4B, top
right quadrant). Intracellular TNF-α stain
showed that < 8% of the CD14+ cells were in
untreated or Pb-treated whole-blood culture.
Approximately 12% of the CD14+ cells in the
LPS group were also TNF-α+. Coexposure to
Pb+LPS increased the number of TNF-α+ cells
to about 20% of the CD14+ cells (Figure 4C).
Macrophages/monocytes mediating
Pb+LPS-induced liver injury. To confirm
whether Pb+LPS-induced liver injury involves
macrophages/monocytes, we inactivated
macrophages/monocytes using GdCl3
(40 mg/kg) 24 hr before Pb+LPS treatment.
Mouse peritoneal macrophages that received
GdCl3 were drastically reduced, and few cells
expressed a high level of F4/80 (F4/80high),
Cheng et al.
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Figure 5. Liver damage after inactivating monocytes/macrophages in A/J mice intravenously injected with GdCl3 (40 mg/kg) or H2O as vehicle (control). After
24 hr, mice were stimulated with Pb, LPS, Pb+LPS, or saline only (control). ND, not detectable. Blood was collected either 1.5 hr posttreatment to determine
serum TNF-α (A) or 24 hr posttreatment to determine serum AST (B) and ALT (C). n = 3 per treatment.
*p < 0.05 compared with Pb+LPS.
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Figure 6. P42/44 MAPK phosphorylation in peritoneal macrophages and RAW264.7 cells. (A) Macrophages from peritoneal exudates were verified using F4/80
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representing peritoneal macrophages in peri-
toneal exudate (data not shown). GdCl3
decreased the level of serum TNF-α in mice
that had received Pb+LPS (Figure 5A). In
parallel with a reduction in TNF-α, GdCl3
markedly decreased serum AST (Figure 5B)
and ALT (Figure 5C) measured 24 hr after
Pb+LPS treatment. GdCl3 also reduced the
number of hepatocellular lesions in mice that
received Pb+LPS, as shown by reduced
necrotic areas in the liver (Figure 2L).
The activation of p42/44 MAPK in
peritoneal macrophages and RAW264.7 cells
treated with Pb+LPS. We examined whether
Pb acted through the common PKC and
p42/44 MAPK pathway to increase LPS-
induced TNF-α expression in peritoneal
macrophages and RAW264.7 cells. The
endothelial cells around large vessels in the liv-
ers of mice treated with Pb+LPS showed phos-
phorylated p42/44 MAPK, but the hepatocytes
did not (data not shown). We further charac-
terized the phosphorylation status of p42/44
MAPK in peritoneal macrophages, which
showed high F4/80 expression (Figure 6A). An
increase in the phosphorylation of p42/44
MAPK in peritoneal macrophages was
observed in the Pb+LPS group (Figure 6B,C).
Similarly, Pb+LPS treatment induced phospho-
rylation of p42/44 MAPK in RAW264.7 cells
(Figure 6D,E).
Effects of PKC and p42/44 MAPK
inhibitors on TNF-α and liver injury in vivo.
To evaluate the actions of PKC and p42/44
MAPK in vivo, mice were treated with either
C21H18NO4Cl (5 mg/kg) 30 min or U0126
(25 µmol/kg) 10 min before being exposed to
Pb, LPS, or Pb+LPS. Both C21H18NO4Cl
and U0126 effectively decreased the serum
TNF-α induced by Pb+LPS (Figure 7A), as
well as the AST and ALT levels elevated by
Pb+LPS (Figure 7B,C). No obvious damage
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Figure 7. PKC and p42/44 MAPK as inhibitors on TNF-α expression and liver damage in mice pretreated (intraperitoneal injection) with C21H18NO4Cl (Ch; 5 mg/kg,
30 min), U0126 (25 µmol/kg, 10 min), or H2O vehicle (control, 30 min) and then stimulated with Pb, LPS, Pb+LPS, or saline only (control). ND, not detectable. Blood
was collected either 1.5 hr after treatment to determine serum TNF-α (A), or 24 hr posttreatment to determine serum AST (B) and ALT (C). n = 3 per treatment.
*p < 0.05 Ch+Pb+LPS or U0126+Pb+LPS compared with Pb+LPS.
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from peritoneal macrophages cultured in a 24-well plate (5 × 105 cells/well). After 24 hr of attachment, cells were stimulated with LPS (0.1 or 1 ng/mL) combined
with Pb (10 µM) for 3 hr. To evaluate the effect of kinase inhibitors, peritoneal macrophages were pretreated with U0126 (B) or C21H18NO4Cl (Ch) (C) for 30 min and
then stimulated with 0.1 ng/mL LPS plus 10 µM Pb for 3 hr. (D) RAW264.7 cells were seeded in a 96-well plate (1 × 104 cells/well) and stimulated for 3 hr with Pb (0,
1, or 10 µM) combined with LPS at various concentrations. To evaluate the effect of kinase inhibitors, RAW264.7 cells were pretreated with U0126 (E) or
C21H18NO4Cl (F) for 30 min and then stimulated with 10 ng/mL LPS plus 10 µM Pb for 3 hr. n = 3.
*p < 0.05 compared with Pb+LPS.occurred in the livers of mice that had received
C21H18NO4Cl or U0126 alone (Figure
2M,Q). Both C21H18NO4Cl and U0126
effectively attenuated the necrotic lesions
developed in the livers of mice after Pb+LPS
treatment (Figure 2P,T).
PKC and p42/44 MAPK in the induction
of TNF-α in peritoneal macrophages and
RAW264.7 cells. Pb (10 µM) significantly
increased the expression of TNF-α induced by
low doses of LPS (0.1 and 1 ng/mL) in mouse
F4/80high peritoneal macrophages (Figure 8A).
In addition, Pb increased the expression of
TNF-α in RAW264.7 cells after treatment
with 1 or 10 ng/mL LPS (Figure 8D). This
Pb-induced increase is more obvious at 10 µM
than at 1 µM.
Using MAPK and PKC inhibitors, we
demonstrated that p42/44 MAPK and PKC
were involved in the Pb+LPS-induced TNF-α
expression of peritoneal macrophages and
RAW264.7 cells. At doses between 7.5 and
30 µM, U0126, a p42/44 MAPK inhibitor,
signiﬁcantly suppressed the Pb+LPS-induced
expression of TNF-α. (Figure 8B,E). At a
dose of 5 µg/mL, C21H18NO4Cl, a PKC
inhibitor, also reduced Pb+LPS-associated
TNF-α expression (Figure 8C,F).
Discussion
Monocytes/macrophages are the primary
secretors of TNF-α during inﬂammation and
infection (Beutler and Cerami 1989). We
demonstrated that the harmful effects of these
cells triggered by LPS may become worse for
the host in the presence of Pb, as reﬂected by
severe liver injury. Inactivating the function of
these phagocytic cells and blocking the signal
pathways for TNF-α production effectively
relieve the damage caused by environmental
insults such as LPS and Pb.
Pb and low doses of LPS neither directly
stimulated TNF-α+ production nor activated
phosphorylation of MAPK in hepatocytes
other than endothelial cells. Previous studies
on the cellular source of TNF-α in animal
exposed to Pb or LPS were not conclusive. Pb
might increase the transcription of TNF-α
mRNA in hepatocytes (Kubo et al. 1996), and
LPS might stimulate liver Kupffer cells to
release TNF-α (Suzuki et al. 1996; Tsukada
et al. 2003). However, in a mixed culture of
hepatocytes and Kupffer cells, Pb and LPS
stimulated only a small increase in the produc-
tion of TNF-α that did not cause obvious cell
death in the cultured hepatocytes (Milosevic
and Maier 2000; Zhang et al. 1996). In our
animal model, serum TNF-α rapidly (within
1.5 hr) reached maximal levels after the
Pb+LPS challenge. Moreover, cells releasing
TNF-α after LPS stimulation in vivo have
been identiﬁed as CD14+ (Haziot et al. 1996;
Perera et al. 1997), but Kupffer cells express
little CD14 (Lichtman et al. 1998). We also
found that the TNF-α induced by Pb+LPS
was expressed primarily by CD14+ cells in the
whole-blood culture and in mouse F4/80+
peritoneal macrophages, which indicates that
the TNF-α was produced by cells outside the
liver. The increase in TNF-α caused by Pb in
the serum of LPS-treated mice was approxi-
mately 10-fold. However, the increase of
TNF-α was only 2-fold in peritoneal
macrophages. This indicates that other cells
and mechanisms might contribute to the Pb-
increased LPS-induced TNF-α production
in vivo and need further investigation.
A second line of evidence excluding
hepatocytes as the source of TNF-α comes
from studies of cell signaling. PKC and
p42/44 MAPK are downstream signals of Pb
stimulation in neurons (Olivi et al. 2003),
bone-marrow–derived macrophages (Flohe
et al. 2002), and glioma cells (Cheng et al.
2004), and they may regulate genes respond-
ing to Pb poisoning. Long-term exposure to
Pb leads to PKC activation in rat livers; how-
ever, Pb also inhibited the activity of PKCα in
a human hepatoma cell line (Liu et al. 1997;
Tonner and Heiman 1997), and the inhibi-
tion was much more pronounced when Pb
levels were high (Sun et al. 1999). Because cir-
culating Pb will quickly deposit in the liver
(Bornemann and Colburn 1985), we specu-
lated (Cheng and Liu 2005) that a transient
accumulation of Pb in the liver will suppress
the activation of PKC and p42/44 MAPK in
hepatocytes. Pb or LPS alone at the doses we
used did not alter the phosphorylation of
p42/44 MAPK in HepG2 cells (data not
shown). In addition, in our animal model, we
did not find phosphorylation of p42/44
MAPK in hepatocytes, further indicating that
they were not induced to produce TNF-α in
response to Pb exposure. In contrast to liver
cells, coexposure to Pb+LPS signiﬁcantly stim-
ulated p42/44 MAPK phosphorylation in
peritoneal macrophages; suppressing p42/44
MAPK phosphorylation or inhibiting PKC
activity resulted in reduced TNF-α expression.
As mentioned above, both Pb and a high
dose of LPS activated PKC and MAPK, which
stimulated TNF-α expression (Cheng et al.
2004). In our study model, the synergistic
effect of Pb+LPS was demonstrable: coexpos-
ing mice to Pb+LPS strongly induced TNF-α
expression in peritoneal macrophages and in
whole blood. In addition, significant inter-
action between the LPS-treatment factor and
Pb-dose factor was indicated by dose-depen-
dent TNF-α expression in different groups of
RAW264.7 cells. Although Pb alone or LPS
alone slightly increased the phosphorylation of
MAPK in peritoneal macrophages, only coex-
posing them to Pb+LPS induced obvious
p42/44 MAPK phosphorylation and TNF-α
expression. Apparently, the minimal level of
MAPK activation required to induce a large
amount of TNF-α was higher than the levels
of MAPK in cells after exposure to a single
dose of Pb alone or LPS alone. After the sig-
nals initiated by Pb+LPS merged in the PKC
and MAPK pathway, MAPK activation was
sufficient for TNF-α production. That an
otherwise insignificant effect of LPS in mice
became vital after the mice had been coex-
posed to Pb+LPS has implications for setting
the maximal tolerable concentration for a par-
ticular pollutant. It seems that risk assessment
based on a single-exposure experimental
design does not truly reﬂect the hazard of an
environmental pollutant to humans.
In conclusion, the PKC/MAPK pathway
leading to TNF-α expression played a key role
in Pb+LPS-induced liver injury in mice. Our
results also indicate that immune cells are very
sensitive to environmental pollution and
emphasize the synergistic effect of multiple
pollutants in disease progression. Speciﬁcally,
monocytes/macrophages may serve as watch-
ful janitors in response to Pb+LPS, even when
it injures their host.
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